We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Therapeutic Efficacy of Estrogen-Related Receptor β in Breast Carcinoma

    Breast cancer mortality is fleeting in females worldwide. Numerous genetic, epigenetic, and environmental factors contribute to breast cancer...
    Sandip K. Mishra, Monalisa Parija, Surya Prakash in Handbook of Oncobiology: From Basic to Clinical Sciences
    Reference work entry 2024
  2. Therapeutic Efficacy of Estrogen-Related Receptor β in Breast Carcinoma

    Breast cancer mortality is fleeting in females worldwide. Numerous genetic, epigenetic, and environmental factors contribute to breast cancer...
    Sandip K. Mishra, Monalisa Parija, Surya Prakash in Handbook of Oncobiology: From Basic to Clinical Sciences
    Living reference work entry 2023
  3. Estrogen Up-Regulates Iron Transporters and Iron Storage Protein Through Hypoxia Inducible Factor 1 Alpha Activation Mediated by Estrogen Receptor β and G Protein Estrogen Receptor in BV2 Microglia Cells

    Estrogen is a steroid hormone produced mainly by the ovaries. It has been found that estrogen could regulate iron metabolism in neurons and...

    Yan Qu, Na Li, ... Jun Wang in Neurochemical Research
    Article 12 July 2022
  4. Estrogen signaling via estrogen receptor alpha and its implications for neurodegeneration associated with Alzheimer’s disease in aging women

    Estrogen receptor alpha (ERα) is a transcription factor activated by estrogenic hormones to regulate gene expression in certain organs, including the...

    Angeles C. Tecalco-Cruz, Lilia López-Canovas, Elisa Azuara-Liceaga in Metabolic Brain Disease
    Article 14 January 2023
  5. Estrogen receptor β deficiency impairs gut microbiota: a possible mechanism of IBD-induced anxiety-like behavior

    Background

    Although the lack of estrogen receptor β (ERβ) is a risk factor for the development of inflammatory bowel disease (IBD) and psychiatric...

    Yuanyuan Ma, Tianyao Liu, ... **aotang Fan in Microbiome
    Article Open access 29 September 2022
  6. All-trans-retinoic acid modulates glycolysis via H19 and telomerase: the role of mir-let-7a in estrogen receptor-positive breast cancer cells

    Background

    Breast cancer (BC) is the most commonly diagnosed cancer in women. Treatment approaches that differ between estrogen-positive (ER+) and...

    Rita El Habre, Rita Aoun, ... George Hilal in BMC Cancer
    Article Open access 21 May 2024
  7. Endogenous estrogen receptor modulating oxysterols and breast cancer prognosis: Results from the MARIE patient cohort

    Background

    27-hydroxycholesterol (HC) and 25-HC were identified as endogenous selective estrogen receptor modulators (SERMs) and estrogen receptor...

    Nina Sophia Decker, Theron Johnson, ... Renée Turzanski Fortner in British Journal of Cancer
    Article Open access 24 June 2023
  8. Chronic Caffeine Consumption, Alone or Combined with Agomelatine or Quetiapine, Reduces the Maximum EEG Peak, As Linked to Cortical Neurodegeneration, Ovarian Estrogen Receptor Alpha, and Melatonin Receptor 2

    Rationale

    Evidence of the effects of chronic caffeine (CAFF)-containing beverages, alone or in combination with agomelatine (AGO) or quetiapine...

    Sherine Abdelmissih, Sara Adel Hosny, ... Nancy F. Samir in Psychopharmacology
    Article Open access 06 June 2024
  9. The Triad of Estrogen, Estrogen Receptors, and Colon Cancer

    Colon cancer is one of the common malignancies in the developed world irrespective of the sexes. The incidence of colon cancer is increasing leaps...
    K. R. Sumalatha, Syamala Soumyakrishnan, M. Sreepriya in Colon Cancer Diagnosis and Therapy Vol. 3
    Chapter 2022
  10. CITED1 as a marker of favourable outcome in anti-endocrine treated, estrogen-receptor positive, lymph-node negative breast cancer

    Objective

    To investigate CITED1 as a potential biomarker of anti-endocrine response and breast cancer recurrence, given its previously determined role...

    Malin Dahlgren, Barbara Lettiero, ... Jillian Howlin in BMC Research Notes
    Article Open access 15 June 2023
  11. Overexpression of estrogen receptor β inhibits cellular functions of human hepatic stellate cells and promotes the anti-fibrosis effect of calycosin via inhibiting STAT3 phosphorylation

    Background

    Estrogen receptor β (ERβ) is the major ER subtype in hepatic stellate cells (HSCs). Previously we reported phytoestrogen calycosin...

    Yaxin Wang, Canyan Wu, ... Jiajia Wang in BMC Pharmacology and Toxicology
    Article Open access 07 October 2022
  12. Nanomedicine in therapeutic warfront against estrogen receptor–positive breast cancer

    Breast cancer (BC) is the most frequently diagnosed malignancy in women worldwide. Almost 70–80% of cases of BC are curable at the early...

    Mayur Aalhate, Srushti Mahajan, ... Pankaj Kumar Singh in Drug Delivery and Translational Research
    Article 16 February 2023
  13. Nogo-B receptor increases glycolysis and the paclitaxel resistance of estrogen receptor-positive breast cancer via the HIF-1α-dependent pathway

    Chemotherapy can improve the prognosis and overall survival of breast cancer patients, but chemoresistance continues a major problem in clinical....

    Chang Liu, Sijie Li, ... Zhimin Fan in Cancer Gene Therapy
    Article 14 October 2022
  14. Expression- and splicing-based multi-tissue transcriptome-wide association studies identified multiple genes for breast cancer by estrogen-receptor status

    Background

    Although several transcriptome-wide association studies (TWASs) have been performed to identify genes associated with overall breast cancer...

    Julian C. McClellan, James L. Li, ... Dezheng Huo in Breast Cancer Research
    Article Open access 21 March 2024
  15. The G Protein Estrogen Receptor (GPER) is involved in the resistance to the CDK4/6 inhibitor palbociclib in breast cancer

    Background

    The cyclin D1-cyclin dependent kinases (CDK)4/6 inhibitor palbociclib in combination with endocrine therapy shows remarkable efficacy in...

    Marianna Talia, Francesca Cirillo, ... Rosamaria Lappano in Journal of Experimental & Clinical Cancer Research
    Article Open access 18 June 2024
  16. Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women

    Fatty liver disease (FLD) caused by metabolic dysfunction is the leading cause of liver disease and the prevalence is rising, especially in women....

    Alessandro Cherubini, Mahnoosh Ostadreza, ... Luca Valenti in Nature Medicine
    Article Open access 25 September 2023
  17. Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer models

    Endocrine therapy (ET) is an effective first-line therapy for women with estrogen receptor-positive (ER + ) breast cancers. While both ionizing...

    Anna R. Michmerhuizen, Lynn M. Lerner, ... Corey W. Speers in npj Breast Cancer
    Article Open access 10 March 2022
  18. Patchouli alcohol as a selective estrogen receptor β agonist ameliorates AD-like pathology of APP/PS1 model mice

    Clinical evidence shows that postmenpausal women are almost twice as likely to develop Alzheimer’s disease (AD) as men of the same age, and estrogen...

    Qiu-ying Yan, Jian-lu Lv, ... Xu Shen in Acta Pharmacologica Sinica
    Article 28 January 2022
  19. Estrogen Receptor Alpha and ESR1 Mutations in Breast Cancer

    The estrogen receptor alphaEstrogen receptor alpha (ERα) is a nuclear transcriptionTranscription factor that is expressed in more than 70% of all...
    Jaymin M. Patel, Rinath M. Jeselsohn in Nuclear Receptors in Human Health and Disease
    Chapter 2022
  20. Astragalin alleviates cognitive deficits and neuronal damage in SAMP8 mice through upregulating estrogen receptor expression

    Senile plaques composed of β-amyloid protein (Aβ) and neurofibrillary tangles (NFTs) composed of intracellular hyper-phosphorylated tau are major...

    Hong Liu, Lili Zhong, ... **g Yang in Metabolic Brain Disease
    Article 19 August 2022
Did you find what you were looking for? Share feedback.